Infectious Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 1
Author(s): Daniele Andreotti
Affiliation:
Export Options
About this article
Cite this article as:
Andreotti Daniele, Meet Our Editorial Board Member, Infectious Disorders - Drug Targets 2016; 16 (1) . https://dx.doi.org/10.2174/187152651601160506180212
DOI https://dx.doi.org/10.2174/187152651601160506180212 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
30
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cessation of HIV-1 Transcription by Inhibiting Regulatory Protein Rev- Mediated RNA Transport
Current HIV Research Patent Foramen Ovale and Thromboembolic Complications
Current Pharmaceutical Design Membrane Damage Induced by Amyloid Beta and a Potential Link with Neuroinflammation
Current Pharmaceutical Design Naturally Occurring and Synthetic Imidazoles: Their Chemistry and Their Biological Activities
Current Medicinal Chemistry Two Experts, One Goal: Collaborative Deprescribing in Psychiatry
Current Psychiatry Reviews Towards a Reconceptualization of Striatal Interactions Between Glutamatergic and Dopaminergic Neurotransmission and Their Contribution to the Production of Movements
Current Neuropharmacology Neurostimulation in Clinical and Sub-clinical Eating Disorders: A Systematic Update of the Literature
Current Neuropharmacology Expression of Opioid Receptors During Peripheral Inflammation
Current Topics in Medicinal Chemistry Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery (Discontinued) Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry The Impact of In Vitro Binding on In Vitro - In Vivo Extrapolations, Projections of Metabolic Clearance and Clinical Drug-Drug Interactions
Current Drug Metabolism Synthesis and Biological Evaluation of Heteroarylnonanenitriles as Potential Antitrypanosomal Agents: Serendipitous Discovery of Novel Anticholinesterase Hits
Letters in Organic Chemistry Moving Beyond Tyrosine Hydroxylase to Define Dopaminergic Neurons for Use in Cell Replacement Therapies for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets An Evidence-Based Review of Antitussive Herbs Containing Essential Oils in Traditional Persian Medicine
Current Drug Discovery Technologies Toll-Like Receptors and Inflammation in the CNS
Current Drug Targets - Inflammation & Allergy The Role of Neuroimaging in the Diagnosis and Treatment of Depressive Disorder: A Recent Review
Current Pharmaceutical Design Analysis of Pralidoxime in Serum, Brain and CSF of Rats
Medicinal Chemistry Autism Spectrum Disorders: The Association with Inherited Metabolic Disorders and Some Trace Elements. A Retrospective Study
CNS & Neurological Disorders - Drug Targets Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry Childhood Hospitalisations for Physical Disease and Risk of Mental Disorders During Adolescence and Early Adulthood
Adolescent Psychiatry